Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Globus Medical, Inc. (NYSE: GMED)
GMED Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
14.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-34.30%
GMED Stock Analysis
GMED
PE Ratio:
18.2
GMED
PEG Ratio:
1.9
GMED
Forward EPS Growth (12 month):
9.40%
GMED
PS Ratio:
3.4
GMED
PSG Ratio:
0.5
GMED
Forward Revenue Growth (12 month):
6.70%
GMED Articles
No data was found